Oxygen Biotherapeutics Highlights Recent Publicans Showing Potential Benefits of Levosimendan
July 09, 2014 at 08:34 AM EDT
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of ...